Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Tax Provisions (2022 - 2025)

Historic Tax Provisions for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $3182.0.

  • bioAffinity Technologies' Tax Provisions rose 2434.54% to $3182.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $40861.0, marking a year-over-year increase of 19305.74%. This contributed to the annual value of $11650.0 for FY2024, which is 4450.53% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Tax Provisions is $3182.0, which was up 2434.54% from $28984.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Tax Provisions registered a high of $28984.0 during Q2 2025, and its lowest value of -$1.0 during Q4 2022.
  • Moreover, its 4-year median value for Tax Provisions was $3182.0 (2025), whereas its average is $5843.2.
  • As far as peak fluctuations go, bioAffinity Technologies' Tax Provisions skyrocketed by 22940000.0% in 2023, and later crashed by 6893.14% in 2024.
  • Over the past 4 years, bioAffinity Technologies' Tax Provisions (Quarter) stood at -$1.0 in 2022, then surged by 229400.0% to $2293.0 in 2023, then rose by 11.6% to $2559.0 in 2024, then rose by 24.35% to $3182.0 in 2025.
  • Its Tax Provisions stands at $3182.0 for Q3 2025, versus $28984.0 for Q2 2025 and $8695.0 for Q1 2025.